FLOVENT (fluticasone propionate)
Currently Approved in US for maintenance treatment of asthma
Approved for COPD in 67 countries outside US
Worldwide exposure estimate - 14.4 million patient years
Approval sought for Flovent Diskus for maintenance treatment of COPD at doses of 250mcg and 500mcg BID